- Colinz Laboratories Ltd
- Colinz Laboratories (BSE)
24.05
Colinz Laboratories Limited is an India-based company, which is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynecological sector. The Company operates and supplies medicines in the domestic market. The Company’s products include oncology, ayurvedic and nutraceuticals. Its oncology products include imatinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, doxorubicin, filgrastim and pegylated liposome doxorubicin. Its ayurvedic products include anti-diarrheas, anti-pyrectics, anti-inflammatories, anti-spasmodic, cough syrups, appetite stimulating agents, memory boosters, anti-piles, antacids, liver tonic, ulcer healing agents, digestive agents, drugs to treat oligospermia and erectile dysfunction, ear drops, uterine tonic, anti-diabetics, and general tonics.
Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.
-
27.21
-
27.18
-
25.48